NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS

The subject matter of the present disclosure generally relates to techniques for neuromodulation that include applying energy (e.g., ultrasound energy) into the tissue to cause a change in a glucose transporter pathway molecule and/or an incretin pathway molecule. In one embodiment, the neuromodulat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Puleo, Christopher Michael, Cotero, Victoria Eugenia, Graf, John Frederick
Format:	Patent
Sprache:	eng
Schlagworte:	DIAGNOSIS ELECTROTHERAPY HUMAN NECESSITIES HYGIENE IDENTIFICATION INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MAGNETOTHERAPY MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS RADIATION THERAPY SURGERY TESTING ULTRASOUND THERAPY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Puleo, Christopher Michael Cotero, Victoria Eugenia Graf, John Frederick
description	The subject matter of the present disclosure generally relates to techniques for neuromodulation that include applying energy (e.g., ultrasound energy) into the tissue to cause a change in a glucose transporter pathway molecule and/or an incretin pathway molecule. In one embodiment, the neuromodulation is performed as a treatment of a metabolic disorder.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2022175306A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2022175306A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2022175306A13</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAuDqL-w4Gz2KZY5yNN20C9K5cL4lSKxEm0UP8fFz_A6S1vnTXkovCF69ijeiZQBkVpnULbR8vBgQpSGFjUCSDVRxbwZMWpJxhQuyvewjZbPabnknY_N9m-cWq7Q5rfY1rm6Z5e6TPGYHJjivOpzCssyv_WF66WLc4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS</title><source>esp@cenet</source><creator>Puleo, Christopher Michael ; Cotero, Victoria Eugenia ; Graf, John Frederick</creator><creatorcontrib>Puleo, Christopher Michael ; Cotero, Victoria Eugenia ; Graf, John Frederick</creatorcontrib><description>The subject matter of the present disclosure generally relates to techniques for neuromodulation that include applying energy (e.g., ultrasound energy) into the tissue to cause a change in a glucose transporter pathway molecule and/or an incretin pathway molecule. In one embodiment, the neuromodulation is performed as a treatment of a metabolic disorder.</description><language>eng</language><subject>DIAGNOSIS ; ELECTROTHERAPY ; HUMAN NECESSITIES ; HYGIENE ; IDENTIFICATION ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MAGNETOTHERAPY ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; RADIATION THERAPY ; SURGERY ; TESTING ; ULTRASOUND THERAPY</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220609&DB=EPODOC&CC=US&NR=2022175306A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220609&DB=EPODOC&CC=US&NR=2022175306A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Puleo, Christopher Michael</creatorcontrib><creatorcontrib>Cotero, Victoria Eugenia</creatorcontrib><creatorcontrib>Graf, John Frederick</creatorcontrib><title>NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS</title><description>The subject matter of the present disclosure generally relates to techniques for neuromodulation that include applying energy (e.g., ultrasound energy) into the tissue to cause a change in a glucose transporter pathway molecule and/or an incretin pathway molecule. In one embodiment, the neuromodulation is performed as a treatment of a metabolic disorder.</description><subject>DIAGNOSIS</subject><subject>ELECTROTHERAPY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>IDENTIFICATION</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MAGNETOTHERAPY</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>RADIATION THERAPY</subject><subject>SURGERY</subject><subject>TESTING</subject><subject>ULTRASOUND THERAPY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAuDqL-w4Gz2KZY5yNN20C9K5cL4lSKxEm0UP8fFz_A6S1vnTXkovCF69ijeiZQBkVpnULbR8vBgQpSGFjUCSDVRxbwZMWpJxhQuyvewjZbPabnknY_N9m-cWq7Q5rfY1rm6Z5e6TPGYHJjivOpzCssyv_WF66WLc4</recordid><startdate>20220609</startdate><enddate>20220609</enddate><creator>Puleo, Christopher Michael</creator><creator>Cotero, Victoria Eugenia</creator><creator>Graf, John Frederick</creator><scope>EVB</scope></search><sort><creationdate>20220609</creationdate><title>NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS</title><author>Puleo, Christopher Michael ; Cotero, Victoria Eugenia ; Graf, John Frederick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2022175306A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>DIAGNOSIS</topic><topic>ELECTROTHERAPY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>IDENTIFICATION</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MAGNETOTHERAPY</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>RADIATION THERAPY</topic><topic>SURGERY</topic><topic>TESTING</topic><topic>ULTRASOUND THERAPY</topic><toplevel>online_resources</toplevel><creatorcontrib>Puleo, Christopher Michael</creatorcontrib><creatorcontrib>Cotero, Victoria Eugenia</creatorcontrib><creatorcontrib>Graf, John Frederick</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Puleo, Christopher Michael</au><au>Cotero, Victoria Eugenia</au><au>Graf, John Frederick</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS</title><date>2022-06-09</date><risdate>2022</risdate><abstract>The subject matter of the present disclosure generally relates to techniques for neuromodulation that include applying energy (e.g., ultrasound energy) into the tissue to cause a change in a glucose transporter pathway molecule and/or an incretin pathway molecule. In one embodiment, the neuromodulation is performed as a treatment of a metabolic disorder.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US2022175306A1
source	esp@cenet
subjects	DIAGNOSIS ELECTROTHERAPY HUMAN NECESSITIES HYGIENE IDENTIFICATION INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MAGNETOTHERAPY MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS RADIATION THERAPY SURGERY TESTING ULTRASOUND THERAPY
title	NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T05%3A02%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Puleo,%20Christopher%20Michael&rft.date=2022-06-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2022175306A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true